Strength Seen in ClearPoint Neuro (CLPT): Can Its 16.9% Jump Turn into More Strength?Zacks Investment Research • 07/10/24
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical TrialGlobeNewsWire • 06/20/24
Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement NeuronsPRNewsWire • 06/20/24
ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy SystemGlobeNewsWire • 06/01/24
Does ClearPoint Neuro (CLPT) Have the Potential to Rally 81.49% as Wall Street Analysts Expect?Zacks Investment Research • 05/29/24
Wall Street Analysts Predict a 70.65% Upside in ClearPoint Neuro (CLPT): Here's What You Should KnowZacks Investment Research • 05/13/24
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ClearPoint Neuro, Inc. (NASDAQ: CLPT)PRNewsWire • 05/02/24
ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN MutationsGlobeNewsWire • 04/16/24
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC DeficiencyGlobeNewsWire • 03/19/24
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024GlobeNewsWire • 03/01/24
ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common StockGlobeNewsWire • 02/29/24